The buisness model described here is absolutely! brilliant. The data collected over time is highly valuble when imenvax becomes a consideration for cancer therapy for humans. The intellectual value of Imenvax "alone" for entest in my opinion is worth a 50 million market cap before any revenue. That would currently price the stock if fully diluted at $0.05 cents.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.